Document is current
Any future updates will be listed below
-
Authors
Gong, Kunxiang
Zheng, Yanqin
Liu, Yaqiong
Zhang, Tiansong
Song, Yiming
Chen, Weiwei
Guo, Lirong
Zhou, Jie
Liu, Wenjie
Fang, Tianlin
Chen, Yun
Wang, Jingyao
Pan, Feifei
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82072859)
Basic and Applied Basic Research Foundation of Guangdong Province (2022A1515220127)
- License Information
-
More Information
Article History
Received: 3 August 2024
Revised: 10 November 2024
Accepted: 18 November 2024
First Online: 16 December 2024
Declarations
:
: The authors declare that they have no competing interests. The authors alone are responsible for the content and writing of this article. Figures were created with BioRender (, accessed on November 10th, 2024).
: The acquisition and use of human specimens were in concordance with the International Ethical Guidelines for Research Involving Human Subjects, as stated in the Helsinki Declaration, and were approved by the Medical Ethics Committee of Guangzhou Women and Children’s Medical Center (No.: 202019001). The EC tumor tissue samples were collected after obtaining signed informed consent from the participants. The use of endometrial cancer tissue microarray was approved by the Ethics Committee of Shanghai Outdo Biotech Company (No.: SHYJS-CP-1504005). The animals experiments were approved by the Guangzhou Women and Children’s Medical Center Animal Welfare and Ethics Committee (KTDW-2024-00480).
: Not applicable.
